|
EDEM1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.222800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.420200E-04 |
| Normal-vs-Stage2 |
1.543780E-01 |
| Normal-vs-Stage3 |
1.001450E-01 |
| Normal-vs-Stage4 |
1.133930E-02 |
| Stage1-vs-Stage2 |
4.908400E-01 |
| Stage1-vs-Stage3 |
2.810200E-01 |
| Stage1-vs-Stage4 |
7.744400E-01 |
| Stage2-vs-Stage3 |
8.758000E-01 |
| Stage2-vs-Stage4 |
4.767200E-01 |
| Stage3-vs-Stage4 |
3.025800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.785100E-04 |
| Normal-vs-AfricanAmerican |
4.994600E-01 |
| Normal-vs-Asian |
1.703970E-01 |
| Caucasian-vs-AfricanAmerican |
1.483450E-01 |
| Caucasian-vs-Asian |
3.339800E-01 |
| AfricanAmerican-vs-Asian |
1.382750E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.496700E-03 |
| Normal-vs-Female |
9.174100E-04 |
| Male-vs-Female |
4.837000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.039600E-01 |
| Normal-vs-Age(41-60Yrs) |
6.158300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.440720E-03 |
| Normal-vs-Age(81-100Yrs) |
7.052800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.674800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.372000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.284800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.363400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.802200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.565600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.521000E-03 |
| Normal-vs-Grade 2 |
3.552700E-04 |
| Normal-vs-Grade 3 |
1.184620E-01 |
| Normal-vs-Grade 4 |
6.237400E-03 |
| Grade 1-vs-Grade 2 |
7.595500E-02 |
| Grade 1-vs-Grade 3 |
6.520400E-03 |
| Grade 1-vs-Grade 4 |
2.602000E-01 |
| Grade 2-vs-Grade 3 |
3.036100E-02 |
| Grade 2-vs-Grade 4 |
5.483600E-01 |
| Grade 3-vs-Grade 4 |
6.141900E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.857760E-03 |
| Normal-vs-ccB subtype |
2.040800E-04 |
| ccA subtype-vs-ccB subtype |
1.942570E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.318850E-03 |
| Normal-vs-N1 |
1.076580E-01 |
| N0-vs-N1 |
3.301200E-01 |
|
|
